Supplementary Figure legends. Supplementary Figure 1. A. Sequence of Tip60 used for modeling. Supplementary Figure 2. Amplification of Kat5 gene from DT40 cells. A. Amplification of full length and indicated Kat5 regions from DT40 cDNA. B. Clustal W alignment of human Kat5 isoform 1 and Gallus gallus Kat5 cDNA. C. Clustal alignment of Chicken, Human and yeast Tip60 proteins. D. Conserved Domains Database (CDD; NCBI) identification of domains in Gallus gallus Kat5 sequence. Supplementary Figure 3. A. Chicken Tip60 (C-Tip60) and Human Tip60 (H-Tip60) share 97% identity in the catalytic acetyltransferase domain. The sequence of C-Tip60 and H-Tip60 with amino acid differences indicated in red.
TH1834 Synthesis.
General: 1 H NMR spectra were recorded on a Bruker, Advance ll (2) (400 MHz), signals are abbreviated as s=singlet; d=doublet; dd=doublets of doublets; t=triplet; q=quartet; quin.=quintet; m=multiplet. Nominal electrospray mass spectrometry (ESMS) was obtained using an Agilent MSD Mass Spectrometer. High-resolution accurate mass (ESI) was recorded on a Bruker Daltonics, micrOTOF instrument.
0.02 mmol) and ethyl 2-[5-(4-formylphenyl)-2H-1,2,3,4-tetrazol-2-yl]acetate (3) (8 mg; 0.03 mmol) in dichloroethane was treated with sodium triacetoxyborhydride (24 mg; 0.1 mmol) and stirred overnight). The mixture was evaporated and the residue was treated with methanol (2.0 ml) and 2M aqueous sodium hydroxide (0.5 ml) then heated at 60°C for 20 min. (
Step1: 4-(4-Formylphenoxy)-N-(2-phenylethyl)butanamide (7) (130 mg, 0.42 mmol) was dissolved in dichloroethane (2.5 ml) and treated with pyrrolidine (36 mg, 0.5 mmol). Acetic acid (25 mg, 0.42 mmol) was added to the solution followed by sodium triacetoxyborohydride (125 mg; 0.59 mmol). The solution was stirred overnight at room temperature. TLC showed revealed the presence of unreacted aldehyde. Accordingly, additional pyrrolidine (36 mg), acetic acid (25 mg), dichloroethane (2.5 ml) and sodium triacetoxyborohydride (125 mg) were added to drive the reaction to completion. The solvent 5 was evaporated and the crude residue was purified with silica gel chromatography (5% methanol in dichloromethane containing 0.1% triethylamine) to give N-(2-phenylethyl)-4-[4- Step 2: A solution of N-(2-phenylethyl)-4-[4-(pyrrolidin-1-ylmethyl)phenoxy]butanamide (prepared in step 1 above) (364 mg; 1 mmol) in anhydrous tetrahydrofuran (4.0 ml) was treated with borane-dimethylsulphide complex (0.5 ml). The mixture was heated at 70°C for 1h then evaporated. Methanol (5.0 ml) was added and the mixture heated for 15 minutes then evaporated. The residue was purified by flash-chromatography over silica (5-20% methanol in dichloromethane) to afford the product (2) (3) ethyl 2- [5-(4-formylphenyl)-2H-1,2,3,4-tetrazol-2-yl] acetate .
A solution of sodium hydride (60% dispersion in mineral oil) (40 mg; 1 mmol) in anhydrous dimethylformamide (5.0 ml) was treated with 4-(2H-1,2,3,4-tetrazol-5-yl)benzaldehyde (5) (174 mg; 1 mmol) and stirred at room temperature until hydrogen evolution had ceased (approximately 15 min.). The mixture was then treated with ethyl bromoacetate (167 mg; 1 mmol) and stirred at room temperature for 5 h. The mixture was quenched with saturated aqueous ammonium chloride solution (3-4 drops) then evaporated and the residue purified by flash-chromatography over silica to give the product (3) 
